Open AccessImmune-related Adverse Effects Associated with Programmed Death-1 Inhibitor Therapy in the Treatment of Non-Small Cell Lung Cancer: Incidence, Management, and Effect on Outcomes
Author(s) -
Timothy Chiu,
Christopher Yamamoto,
Fang Niu,
Helen Moon,
ThachGiao Truong,
Robert Cooper,
Rita L. Hui
Publication year - 2020
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/20.034
Subject(s) - medicine , hazard ratio , interquartile range , immunosuppression , nivolumab , adverse effect , lung cancer , retrospective cohort study , confidence interval , oncology , cancer , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom